All Stories

  1. Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria
  2. Binding of ruthenium and osmium at non‑iron sites of transferrin accounts for their iron-independent cellular uptake
  3. Metalloproteomics for Biomedical Research: Methodology and Applications
  4. Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
  5. Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation
  6. A hydroxide lock for metallo-β-lactamases
  7. Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
  8. Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers
  9. Metal-based strategies for the fight against COVID-19
  10. Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL
  11. Eradication of Porphyromonas gingivalis Persisters Through Colloidal Bismuth Subcitrate Synergistically Combined With Metronidazole
  12. Author Correction: Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  13. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  14. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
  15. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
  16. A. Sigel, E. Freisinger & R. K. O. Sigel (Eds.), M. E. Sosa Torres & P. M. H. Kroneck (volume Eds.): Transition Metals and Sulfur – A Strong Relationship for Life
  17. Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
  18. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
  19. Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development
  20. Bismuth—The Magic Element
  21. Atomic differentiation of silver binding preference in protein targets:Escherichia colimalate dehydrogenase as a paradigm
  22. Bismuth drugs as antimicrobial agents
  23. Predicting disease-associated mutation of metal-binding sites in proteins using a deep learning approach
  24. Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli
  25. Recognition of Proteins by Metal Chelation-Based Fluorescent Probes in Cells
  26. Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs
  27. Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli
  28. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells
  29. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping
  30. A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein
  31. Green Fluorescent Probe for Imaging His6-Tagged Proteins Inside Living Cells
  32. MetaMarker: a pipeline for de novo discovery of novel metagenomic biomarkers
  33. Antimicrobial silver targets glyceraldehyde-3-phosphate dehydrogenase in glycolysis of E. coli
  34. Bismuth: Environmental Pollution and Health Effects
  35. Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
  36. S-Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells
  37. Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection
  38. Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells
  39. The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum
  40. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
  41. Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials
  42. Multi-omics and temporal dynamics profiling reveal disruption of central metabolism inHelicobacter pylorion bismuth treatment
  43. Tracking iron-associated proteomes in pathogens by a fluorescence approach
  44. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival
  45. A Ni-NTA-based red fluorescence probe for protein labelling in live cells
  46. Cytotoxicity of arsenic trioxide in single leukemia cells by time-resolved ICP-MS together with lanthanide tags
  47. Identification of catabolite control protein A fromStaphylococcus aureusas a target of silver ions
  48. Integration of fluorescence imaging with proteomics enables visualization and identification of metallo-proteomes in living cells
  49. Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori
  50. Exploration into the nickel ‘microcosmos’ in prokaryotes
  51. UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori
  52. Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells
  53. Rapid labeling of intracellular His-tagged proteins in living cells
  54. Loss of APD1 in Yeast Confers Hydroxyurea Sensitivity Suppressed by Yap1p Transcription Factor
  55. Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs
  56. “Anion clamp” allows flexible protein to impose coordination geometry on metal ions
  57. On-line coupling of continuous-flow gel electrophoresis with inductively coupled plasma-mass spectrometry to quantitatively evaluate intracellular metal binding properties of metallochaperones HpHypA and HpHspA in E. coli cells
  58. Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography
  59. Selective interaction of Hpn-like protein with nickel, zinc and bismuth in vitro and in cells by FRET
  60. Antimony and Bismuth
  61. Structure of RPA32 bound to the N-terminus of SMARCAL1 redefines the binding interface between RPA32 and its interacting proteins
  62. Urease inactivation by an unusual GroES chaperonin
  63. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth
  64. In-cell NMR: an emerging approach for monitoring metal-related events in living cells
  65. Size-tunable fabrication of multifunctional Bi2O3 porous nanospheres for photocatalysis, bacteria inactivation and template-synthesis
  66. Nickel translocation between metallochaperones HypA and UreE in Helicobacter pylori
  67. BiOX (X=Cl, Br, I) nanostructures: Mannitol-mediated microwave synthesis, visible light photocatalytic performance, and Cr(VI) removal capacity
  68. Identification of Metal-Associated Proteins in Cells by Using Continuous-Flow Gel Electrophoresis and Inductively Coupled Plasma Mass Spectrometry
  69. ChemInform Abstract: Template-Free Fabrication of Bi2O3and (BiO)2CO3Nanotubes and Their Application in Water Treatment.
  70. Tunable BiOCl hierarchical nanostructures for high-efficient photocatalysis under visible light irradiation
  71. Kinetics and thermodynamics of metal binding to the N-terminus of a human copper transporter, hCTR1
  72. Binding of oxo-Cu2 clusters to ferric ion-binding protein A from Neisseria gonorrhoeae: a structural insight
  73. Histidine-rich proteins in prokaryotes: metal homeostasis and environmental habitat-related occurrence
  74. Interaction of SlyD with HypB of Helicobacter pylori facilitates nickel trafficking
  75. Structure-oriented bioinformatic approach exploring histidine-rich clusters in proteins
  76. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe
  77. Template-Free Fabrication of Bi2O3and (BiO)2CO3Nanotubes and Their Application in Water Treatment
  78. Metallomics in environmental and health related research: Current status and perspectives
  79. Facile Microwave Synthesis of 3D Flowerlike BiOBr Nanostructures and Their Excellent Cr VI Removal Capacity
  80. Recent advances in bioinorganic chemistry of bismuth
  81. Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
  82. Covalently linking the Escherichia coli global anaerobic regulator FNR in tandem allows it to function as an oxygen stable dimer
  83. Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA
  84. Large-scale synthesis of bismuth hollow nanospheres for highly efficient Cr(vi) removal
  85. Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)
  86. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)
  87. Probing of bismuth antiulcer drug targets in H. pylori by laser ablation-inductively coupled plasma mass spectrometry
  88. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation
  89. Microwave synthesis of BiPO4 nanostructures and their morphology-dependent photocatalytic performances
  90. Assembly of Preactivation Complex for Urease Maturation inHelicobacter pylori
  91. Histidine-rich protein Hpn from Helicobacter pylori forms amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells
  92. Tracking Bismuth Antiulcer Drug Uptake in Single Helicobacter pylori Cells
  93. Metal-Binding Properties of an Hpn-Like Histidine-Rich Protein
  94. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  95. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  96. NMR Studies of Metalloproteins
  97. Biological Chemistry of Arsenic, Antimony and Bismuth
  98. Biological Chemistry of Antimony and Bismuth
  99. Metalloproteomics of Arsenic, Antimony and Bismuth Based Drugs
  100. Polymeric architectures of bismuth citrate based on dimeric building blocks
  101. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization
  102. Iron-containing lipoprotein SiaA in SiaABC, the primary heme transporter of Streptococcus pyogenes
  103. ChemInform Abstract: Transferrin as a Metal Ion Mediator
  104. Nuclear-based Metallomics in Metal-based Drugs
  105. Bismuth subcarbonate nanoparticles fabricated by water-in-oil microemulsion-assisted hydrothermal process exhibit anti-Helicobacter pylori properties
  106. A new capillary electrophoresis buffer for determining organic and inorganic anions in electroplating bath with surfactant additives
  107. A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
  108. A biomimetic zinc activated ion channel
  109. Metallomics: An integrated science for metals in biology and medicine
  110. Metallomics: An integrated biometal science
  111. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
  112. Effect of cyclodextrin dimers with bipyridyl and biphenyl linking groups on carboxyl ester hydrolysis catalyzed by zinc complex
  113. Structure of a Nickel Chaperone, HypA, from Helicobacter pylori Reveals Two Distinct Metal Binding Sites
  114. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2
  115. The structural and biological significance of the EAAEAE insert in the α-domain of human neuronal growth inhibitory factor
  116. Crystal Structure and Metal Binding Properties of the Lipoprotein MtsA, Responsible for Iron Transport in Streptococcus pyogenes
  117. Phosphodiester hydrolysis and specific DNA binding and cleavage promoted by guanidinium-functionalized zinc complexes
  118. Important roles of the conserved linker-KKS in human neuronal growth inhibitory factor
  119. Identification and characterization of metallodrug binding proteins by (metallo)proteomics
  120. Editorial and Advisory Board profiles
  121. Identification of Proteins Related to Nickel Homeostasis in Helicobater pylori by Immobilized Metal Affinity Chromatography and Two-Dimensional Gel Electrophoresis
  122. Study on structure–property–reactivity–function relationship of human neuronal growth inhibitory factor (hGIF)
  123. Binding of Ni2+ to a histidine- and glutamine-rich protein, Hpn-like
  124. Structure, topology and assembly of a 32-mer peptide corresponding to the loop 3 and transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  125. A Histidine-rich and Cysteine-rich Metal-binding Domain at the C Terminus of Heat Shock Protein A from Helicobacter pylori
  126. Lipoprotein MtsA of MtsABC inStreptococcus pyogenesprimarily binds ferrous ion with bicarbonate as a synergistic anion
  127. Double-strand DNA cleavage by copper complexes of 2,2′-dipyridyl with guanidinium/ammonium pendants
  128. The effect of nitric oxide on metal release from metallothionein-3: gradual unfolding of the protein
  129. Biocoordination chemistry of bismuth: Recent advances
  130. Bismuth Complexes Inhibit the SARS Coronavirus
  131. Bismuth Complexes Inhibit the SARS Coronavirus
  132. Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor
  133. Bioinorganic Chemistry of Bismuth and Antimony: Target Sites of Metallodrugs
  134. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori
  135. Structural prediction of the β-domain of metallothionein-3 by molecular dynamics simulation
  136. Solution structures, dynamics, and lipid-binding of the sterile α-motif domain of the deleted in liver cancer 2
  137. Metallodrugs
  138. An Effective Metallohydrolase Model with a Supramolecular Environment: Structures, Properties, and Activities
  139. Bioinorganic Chemistry of Bismuth and Antimony:  Target Sites of Metallodrugs
  140. Silver nanoparticles: partial oxidation and antibacterial activities
  141. Synthesis, Structure, and Activity of Supramolecular Mimics for the Active Site and Arg141 Residue of Copper, Zinc−Superoxide Dismutase
  142. Encapsulation of platinum anticancer drugs by apoferritin
  143. Inhibition of SARS coronavirus helicase by bismuth complexes
  144. Cleavage of double-strand DNA by zinc complexes of dicationic 2,2′-dipyridyl derivatives
  145. Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania
  146. Inhibition of urease by bismuth(III): Implications for the mechanism of action of bismuth drugs
  147. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3
  148. Thermodynamic and Kinetic Aspects of Metal Binding to the Histidine-rich Protein, Hpn
  149. The role of Thr5 in human neuron growth inhibitory factor
  150. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
  151. Solution structure and dynamics of human metallothionein-3 (MT-3)
  152. HFIP-induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1
  153. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate
  154. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni 2+ storage in Helicobacter pylori
  155. 51Sb Antimony in Medicine
  156. Complexation of antimony (SbV) with guanosine 5′-monophosphate and guanosine 5′-diphospho-d-mannose: Formation of both mono- and bis-adducts
  157. An Insight of S-Nitrosylation of Human GIF
  158. The Stepwise Process of Chromium-Induced DNA Breakage:  Characterization by Electrochemistry, Atomic Force Microscopy, and DNA Electrophoresis
  159. Dynamic and Kinetic Aspects of Metallodrugs by NMR
  160. Transferrin-Mediated Gold Nanoparticle Cellular Uptake
  161. NMR structures and orientation of the fourth transmembrane domain of the rat divalent metal transporter (DMT1) with G185D mutation in SDS micelles
  162. Structure, Assembly, and Topology of the G185R Mutant of the Fourth Transmembrane Domain of Divalent Metal Transporter
  163. Controlled synthesis of high crystalline bismuth sulfide nanorods: using bismuth citrate as a precursor
  164. In Vitro Inhibition of Human Immunodeficiency Virus Type-1 (HIV-1) Reverse Transcriptase by Gold(III) Porphyrins
  165. The low pKavalue of iron-binding ligand Tyr188 and its implication in iron release and anion binding of human transferrin
  166. Inhibition of alcohol dehydrogenase by bismuth☆
  167. Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane-mimetic environments
  168. Bismuth in Medicine
  169. DNA hydrolysis promoted by di- and multi-nuclear metal complexes
  170. Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl:  Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit)2Bi]2-)
  171. Recognition of antimony and bismuth by peptides and proteins: insight into the mechanism of action
  172. Three dimensional structures and topology of the transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  173. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione
  174. Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter
  175. Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma
  176. Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details...
  177. Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activationElectronic supplementary information (ESI) available: experimental details. See
  178. Complexation of ytterbium to human transferrin and its uptake by K562 cells
  179. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
  180. The role of the transferrin–transferrin-receptor system in drug delivery and targeting
  181. Interactions of Bismuth with Human Lactoferrin and Recognition of the BiIII−Lactoferrin Complex by Intestinal Cells
  182. Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
  183. Intracellular Sb-trypanothione
  184. Complexation of Antimony(III) by Trypanothione
  185. Interaction of antimony tartrate with the tripeptide glutathione
  186. TiIV Uptake and Release by Human Serum Transferrin and Recognition of TiIV-Transferrin by Cancer Cells:  Understanding the Mechanism of Action of the Anticancer Drug Titanocene Dichloride
  187. Stereoselective Formation of Seven-Coordinate Titanium(IV) Monomer and Dimer Complexes of Ethylenebis(o-hydroxyphenyl)glycine
  188. Interactions of Bismuth Complexes with Metallothionein(II)
  189. Transferrin as a Metal Ion Mediator
  190. Coordination chemistry of metals in medicine: target sites for bismuth
  191. Bismuth Antiulcer Complexes
  192. N-lobe versus C-lobe complexation of bismuth by human transferrin
  193. Coordination of Zn2+ (and Cd2+) by Prokaryotic Metallothionein
  194. The First Specific TiIV-Protein Complex: Potential Relevance to Anticancer Activity of Titanocenes
  195. [1H,13C] NMR determination of the order of lobe loading of human transferrin with iron: comparison with other metal ions
  196. New approach to the solution chemistry of bismuth citrate antiulcer complexes
  197. The Biological and Medicinal Chemistry of Bismuth
  198. Determination of Bismuth in Serum Urine by Direct Injection Nebulization Inductively Coupled Plasma Mass Spectrometry
  199. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants
  200. Rationalization of the Strength of Metal Binding to Human Serum Transferrin
  201. Molecular assemblies of diazafluorenone Schiff-base amphiphiles. III.13C NMR investigations of reversed micelles in deuteriochloroform
  202. Bismuth(III) Complexes of the Tripeptide Glutathione (γ-L-Glu–L-Cys–Gly)
  203. Solid-state carbon-13 nuclear magnetic resonance investigations of bismuth citrate complexes and crystal structure of Na2[Bi2(cit)2]·7H2O
  204. 1H NMR Studies of the Imidazole Complex of Cytochrome c: Resonance Assignment and Structural Characterization of the Heme Cavity
  205. Ranitidine bismuth(III) citrate
  206. NMR Investigation of the Aggregation Behavior of Diazafluorenone Schiff Base Amphiphile in CDCL3Solution
  207. Assignments of Nonexchangeable Proton Resonances and the Solution Structures of d–TGGGT
  208. Syntheses and Characterization of Coenzyme B12 Analogues Containing 2′-Deoxynucleosede
  209. Two Dimensional1HNMR Studies on 2′5′-Dideoxyadenosylcobalamin